16 research outputs found

    Utilización del Diazafluorenona (DFO) como alternativa para el revelado de huellas dactilares latentes en superficies porosas.

    Get PDF
    El presente trabajo de investigación fue realizado teniendo como objetivo principal, proponer la utilización del diazafluorenona (DFO) como alternativa para revelado de huellas dactilares latentes en superficies porosas como el papel, a causa que existen muchas situaciones y circunstancias en que las técnicas más convencionales o más utilizadas, como por ejemplo los reveladores físicos de tipo polvo, no son apropiadas para poder revelar huellas dactilares, ya que hay factores como el cambio climático o la acción del tiempo que no permiten su uso. Esta investigación fue realizada mediante un estudio de tipo bibliográfico y documental, ya que se utilizaron diferentes fuentes bibliográficas, que permitieron obtener la información necesaria, a fin de proponer el uso del reactivo Diazafluorenona como alternativa para el revelado de huellas dactilares. Como producto final de esta investigación, se presentó una propuesta de practica de laboratorio, que podrá retomarse como base en futuras investigaciones sobre este tema. Además, se pretende que se valore su implementación en los laboratorios de Química Forense y Toxicología de la Licenciatura en Química y Farmacia. La utilización del diazafluorenona como una alternativa para el revelado de huellas dactilares latentes en superficies porosas como el papel, es una técnica moderna y eficaz gracias a su característica principal que es la fluorescencia, porque es mejor obtener una huella débilmente fluorescente que una huella débilmente coloreada. Este trabajo se desarrolló como producto final del Curso de Especialización de Análisis Químico Aplicado a la Investigación Criminal de la Facultad de Química y Farmacia de la Universidad de El Salvador y se ejecutó en un período de 6 meses bajo la modalidad a distanci

    Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead

    Get PDF
    Background: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, P01AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like “Reserve,” there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC.Facultad de Ciencias Médica

    Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

    Get PDF
    To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC

    Novel therapies targeting cardioprotection and regeneration

    No full text
    Cardiovascular disease is the leading cause of death worldwide. The heart is susceptible to pathologies that impact the myocardium directly, such as myocardial infarction and consequent heart failure, as well as conditions with indirect cardiac effects, such as cancer treatment-related cardiotoxicity. As the contractile cells of the heart, cardiomyocytes are essential for normal cardiac function. Various stress stimuli may result in transient damage or cell death in cardiomyocytes through apoptosis, necrosis or maladaptive autophagy. Moreover, cardiomyocytes are unable to regenerate; thus, lost cells are replaced with fibrotic tissue, with a potentially severe impact on myocardial function. Several therapeutic agents and strategies to reduce cardiomyocyte damage are currently available. This manuscript reviews the state of the art regarding novel cardioprotective endogenous peptides, such as neuregulin-1, angiotensin-(1-9), growth/differentiation factor-11, growth/differentiation factor15 and insulin-like growth factor-1. We discuss their protective effects and therapeutic potential in cardiovascular diseases and the current challenges to harnessing their full cardioprotective power. We also explore targeting of exosomes as a cardioprotective approach along with the therapeutic potential of cardiac regeneration strategies. Further advances associated with these molecules and cardioprotective approaches may provide more effective therapies to attenuate or prevent cardiomyocyte death, thereby preserving the myocardium.Fondo Nacional de Desarrollo Cientifico y Tecnologico: FONDAP FONDAP 15130011 FONDAP 15090007 FONDEF D11/1122 FONDECYT 1141137 FONDECYT postdoctoral fellowships 3160298 3160287 3160086 PhD fellowships from CONICYT 21140239 63140060 Colciencia
    corecore